Accra, March 21, GNA – Precision medicine company Revna Biosciences (RevnaBio) has secured triple accreditation from the American Association for Laboratory Accreditation (A2LA) to strengthen its ...

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre.

Timely diagnosis of debilitating and often deadly brain diseases such as Alzheimer’s and Parkinson’s remains largely elusive, though in recent years several teams of scientists have reported potential ...